Skip to main content
CDT
NASDAQ Life Sciences

CDT Equity Inc. Implements 1-for-25 Reverse Stock Split to Boost Share Price

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.44
Mkt Cap
$2.183M
52W Low
$0.442
52W High
$168
52W Position info
0.5% below low
Off High info
100% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

CDT is trading near its 52-week low of $0.442 (0.5% below the low) on light trading volume (0.1× avg).

Summary

CDT Equity Inc. will implement a 1-for-25 reverse stock split effective March 26, 2026, to increase its share price, likely to maintain its Nasdaq listing.


Key Events · Corporate Governance and Compliance · CDT

  • Reverse Stock Split Details

    CDT Equity Inc. filed a certificate of amendment to effectuate a 1-for-25 reverse stock split of its common stock, effective March 26, 2026, at 5:00 p.m. Eastern Time.

  • Nasdaq Trading Adjustment

    The common stock is expected to begin trading on The Nasdaq Capital Market on a reverse stock split-adjusted basis on March 27, 2026, under the existing ticker symbol 'CDT'.

  • Fractional Shares Handled by Cash Payment

    No fractional shares will be issued; stockholders entitled to a fractional share will receive a cash payment based on the closing price on March 26, 2026.

  • Share Count Reduction

    After the reverse stock split, the number of outstanding shares of common stock will be reduced to approximately 4,722,450.


Analysis · CDT · Life Sciences

CDT Equity Inc. is executing a significant 1-for-25 reverse stock split, a common maneuver for companies whose stock price has fallen below exchange minimums, likely to maintain its Nasdaq listing. While it increases the per-share price, it does not change the company's overall market capitalization or fundamental value. Investors should be aware that reverse splits often precede further price declines if the underlying business issues are not resolved. The company's stock is currently trading near its 52-week low, underscoring the urgency of this action. The reduction in outstanding shares could lead to increased volatility.

At the time of this filing, CDT was trading at $0.44 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.2M. The 52-week trading range was $0.44 to $168.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CDT - Latest Insights

CDT
Jul 16, 2026, 8:05 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.322
Real-time Price: $2.90 info
Change: Reverse Stock Split info
Market Cap: $1.795M info
CDT
Jul 16, 2026, 8:04 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.2815
Real-time Price: $2.90 info
Change: Reverse Stock Split info
Market Cap: $1.795M info
CDT
Jul 15, 2026, 4:51 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.3503
Real-time Price: $2.90 info
Change: Reverse Stock Split info
Market Cap: $1.795M info
CDT
Jul 15, 2026, 4:46 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.3503
Real-time Price: $2.90 info
Change: Reverse Stock Split info
Market Cap: $1.795M info
CDT
Jul 07, 2026, 5:20 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.425
Real-time Price: $2.90 info
Change: Reverse Stock Split info
Market Cap: $1.795M info